Legislation to remove CMS restrictions on anemia drugs

10/2/2007 | Hill, The

A Democrat and a Republican have introduced legislation in Congress that would overturn a July CMS decision to restrict reimbursements for erythropoiesis-stimulating drugs that treat anemia in cancer patients. The legislation says the CMS policy puts patients at risk by restricting access to the drugs, including Amgen's Epogen and Aranesp and Johnson & Johnson's Procrit.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC